Ipca Laboratories reports 22% rise in its FY11 net profit

25 May 2011 Evaluate

Ipca Laboratories has reported results for the year ended March 31, 2011.

The company has posted a net profit of Rs 255.37 crore for FY11, up by 22.08% as compared to Rs 209.19 crore in the last year. Total income has increased by 21.15% to Rs 1881.10 crore for the year under review from Rs 1552.74 crore in previous year.

On consolidated basis, the net profit has rose by 27.98% at Rs 262.82 crore for FY11 as compared to Rs 205.36 crore for FY10. Its total income has increased by 21.20% to Rs 1898.86 crore for the year under review from Rs 1566.76 crore a period ago.

Ipca Laboratories has recommended a final dividend of Rs 1.20 per share or 60% for the financial year ended March 31, 2011.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×